1. Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis.
- Author
-
Kusner J, Patel RB, Hu M, Bertoni AG, Michos ED, Pandey A, VanWagner LB, Shah S, and Fudim M
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Stroke Volume physiology, Tomography, X-Ray Computed, Aged, 80 and over, United States epidemiology, Body Mass Index, Ethnicity, Liver diagnostic imaging, Liver metabolism, Fatty Liver ethnology, Fatty Liver diagnosis, Fatty Liver physiopathology, Echocardiography, Adiposity ethnology, Risk Factors, Biomarkers blood, Heart Failure ethnology, Heart Failure physiopathology, Heart Failure epidemiology, Atherosclerosis ethnology
- Abstract
Background: Metabolic dysfunction associated steatotic liver disease (MASLD) has been linked to heart failure with preserved ejection fraction (HFpEF). We sought to understand association between individuals with amounts of liver adiposity greater than would be predicted by their body mass index (BMI) in order to understand whether this disproportionate liver fat (DLF) represents a proxy of metabolic risk shared between liver and heart disease., Methods: We studied 2,932 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) who received computed tomography (CT) measurements of hepatic attenuation. Quartiles of DLF were compared and multivariable linear regression was performed to evaluate the association of DLF with clinical, echocardiographic, and quality of life metrics., Results: Compared to the lowest quartile of DLF, individuals in the highest quartile of DLF were more likely to be male (52.0% vs 47.1%, P < .001), less likely to be Black or African American (14.8 % vs 38.1% P < .001), have higher rates of dysglycemia (31.9% vs 16.6%, P < .001) and triglycerides (140 [98.0, 199.0] vs 99.0 [72.0, 144.0] mg/dL, P > .001). These individuals had lower global longitudinal strain (-0.13 [-0.25, -0.02], P = .02), stroke volumes (-1.05 [-1.76, -0.33], P < .01), lateral e' velocity (-0.10 [-0.18, -0.02], P = .02), and 6-minute walk distances (-4.25 [-7.62 to -0.88], P = .01)., Conclusion: DLF is associated with abnormal metabolic profiles and ventricular functional changes known to be associated with HFpEF and may serve as an early metric to assess for those that may progress to clinical HFpEF., Competing Interests: Declaration of competing interest The authors have no conflicts of interest to declare., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF